Avian influenza A (H7N9) virus: from low pathogenic to highly pathogenic.


Journal

Frontiers of medicine
ISSN: 2095-0225
Titre abrégé: Front Med
Pays: China
ID NLM: 101549428

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 15 02 2020
accepted: 08 07 2020
pubmed: 17 4 2021
medline: 21 8 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

The avian influenza A (H7N9) virus is a zoonotic virus that is closely associated with live poultry markets. It has caused infections in humans in China since 2013. Five waves of the H7N9 influenza epidemic occurred in China between March 2013 and September 2017. H7N9 with low-pathogenicity dominated in the first four waves, whereas highly pathogenic H7N9 influenza emerged in poultry and spread to humans during the fifth wave, causing wide concern. Specialists and officials from China and other countries responded quickly, controlled the epidemic well thus far, and characterized the virus by using new technologies and surveillance tools that were made possible by their preparedness efforts. Here, we review the characteristics of the H7N9 viruses that were identified while controlling the spread of the disease. It was summarized and discussed from the perspectives of molecular epidemiology, clinical features, virulence and pathogenesis, receptor binding, T-cell responses, monoclonal antibody development, vaccine development, and disease burden. These data provide tools for minimizing the future threat of H7N9 and other emerging and re-emerging viruses, such as SARS-CoV-2.

Identifiants

pubmed: 33860875
doi: 10.1007/s11684-020-0814-5
pii: 10.1007/s11684-020-0814-5
pmc: PMC8190734
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

507-527

Informations de copyright

© 2021. The Author(s).

Références

Nat Rev Microbiol. 2014 Dec;12(12):822-31
pubmed: 25383601
J Virol. 2018 Aug 16;92(17):
pubmed: 29925664
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1049-54
pubmed: 24395804
Antiviral Res. 2019 Oct;170:104564
pubmed: 31336147
Expert Rev Vaccines. 2015;14(10):1313-29
pubmed: 26289975
PLoS One. 2014 Mar 24;9(3):e92823
pubmed: 24664315
Emerg Infect Dis. 2019 Dec;25(12):2215-2225
pubmed: 31742536
N Engl J Med. 2013 May 16;368(20):1888-97
pubmed: 23577628
J Immunol. 2007 Jan 15;178(2):1030-8
pubmed: 17202366
J Virol. 2006 Dec;80(23):11756-66
pubmed: 16971435
Trends Microbiol. 2017 Sep;25(9):713-728
pubmed: 28734617
Virol J. 2015 May 05;12:71
pubmed: 25940512
J Virol. 2018 Jan 2;92(2):
pubmed: 29070694
BMC Infect Dis. 2018 Dec 14;18(1):664
pubmed: 30551738
EMBO J. 2014 Apr 16;33(8):823-41
pubmed: 24668228
Science. 2013 Oct 11;342(6155):243-7
pubmed: 24009358
J Infect Dis. 2011 Sep 15;204(6):845-53
pubmed: 21846636
Proc Natl Acad Sci U S A. 2012 Oct 16;109(42):17040-5
pubmed: 23027945
Nat Commun. 2015 Mar 30;6:6714
pubmed: 25819694
J Infect. 2019 Mar;78(3):241-248
pubmed: 30664912
mBio. 2019 Jun 18;10(3):
pubmed: 31213560
Lancet. 2013 Jun 1;381(9881):1916-25
pubmed: 23623390
J Infect. 2017 Aug;75(2):179-182
pubmed: 28535998
Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14216-21
pubmed: 21825125
Sci China Life Sci. 2017 Dec;60(12):1383-1385
pubmed: 28887624
Cell Host Microbe. 2017 Oct 11;22(4):471-483.e5
pubmed: 28966056
Euro Surveill. 2014 Jun 26;19(25):
pubmed: 24993557
Lancet Infect Dis. 2017 Aug;17(8):822-832
pubmed: 28583578
BMC Public Health. 2017 Nov 25;17(1):898
pubmed: 29178863
Sci Rep. 2016 Sep 27;6:33843
pubmed: 27669665
PLoS Pathog. 2017 Jun 15;13(6):e1006390
pubmed: 28617868
Cell Rep. 2013 Mar 28;3(3):769-78
pubmed: 23434510
Nature. 2013 Sep 26;501(7468):551-5
pubmed: 23842494
PLoS One. 2015 Jan 28;10(1):e0117108
pubmed: 25629172
Science. 2012 Sep 14;337(6100):1343-8
pubmed: 22878502
J Virol. 2018 Feb 12;92(5):
pubmed: 29212936
Nature. 2012 Sep 27;489(7417):526-32
pubmed: 22982990
J Virol. 2018 May 14;92(11):
pubmed: 29563296
J Clin Invest. 2016 Apr 1;126(4):1482-94
pubmed: 26950424
Sci Rep. 2016 Jan 19;6:19474
pubmed: 26782141
Nat Struct Mol Biol. 2013 Mar;20(3):363-70
pubmed: 23396351
Jpn J Infect Dis. 2005 Aug;58(4):195-207
pubmed: 16116250
Antiviral Res. 2016 Nov;135:48-55
pubmed: 27713074
Sci Rep. 2016 Oct 14;6:35401
pubmed: 27739468
Sci Bull (Beijing). 2018 Aug 30;63(16):1043-1050
pubmed: 32288966
Sci Rep. 2015 Jun 01;5:10942
pubmed: 26028236
PLoS Pathog. 2016 Apr 15;12(4):e1005578
pubmed: 27081859
J Infect Dis. 2014 Feb 15;209(4):551-6
pubmed: 23990570
mBio. 2018 Aug 7;9(4):
pubmed: 30087171
Int J Infect Dis. 2019 Apr;81:244-250
pubmed: 30797966
J Virol. 2018 Dec 10;93(1):
pubmed: 30305359
Sci China Life Sci. 2013 Jun;56(6):485-92
pubmed: 23657795
Euro Surveill. 2019 May;24(21):
pubmed: 31138362
Emerg Microbes Infect. 2019;8(1):94-102
pubmed: 30866763
Emerg Microbes Infect. 2018 Jun 20;7(1):110
pubmed: 29925896
Science. 2014 Apr 18;344(6181):235
pubmed: 24744345
Emerg Microbes Infect. 2019;8(1):1157-1167
pubmed: 31373538
Euro Surveill. 2013 Oct 24;18(43):
pubmed: 24176616
Cell Host Microbe. 2019 Dec 11;26(6):715-728.e8
pubmed: 31757769
PLoS One. 2015 Mar 23;10(3):e0120793
pubmed: 25799397
Clin Infect Dis. 2013 Nov;57(10):1449-57
pubmed: 23943822
Euro Surveill. 2013 Apr 11;18(15):20453
pubmed: 23594575
Annu Rev Biochem. 1987;56:365-94
pubmed: 3304138
Cell Host Microbe. 2013 Oct 16;14(4):446-52
pubmed: 24055604
N Engl J Med. 2013 Jun 13;368(24):2277-85
pubmed: 23697469
Antiviral Res. 2019 Oct;170:104556
pubmed: 31299269
J Virol. 2014 Mar;88(6):3568-76
pubmed: 24403592
Curr Top Microbiol Immunol. 2015;386:275-99
pubmed: 25033754
N Engl J Med. 2013 Dec 26;369(26):2564-6
pubmed: 24224560
Nat Commun. 2018 Feb 26;9(1):824
pubmed: 29483513
Cell Host Microbe. 2017 Nov 8;22(5):615-626.e8
pubmed: 29056430
J Virol. 2010 Oct;84(19):9957-66
pubmed: 20668069
Sci China Life Sci. 2018 Sep;61(9):1123-1126
pubmed: 29995198
Cell Host Microbe. 2016 Jun 8;19(6):800-13
pubmed: 27281570
Lancet. 2014 Feb 8;383(9916):541-8
pubmed: 24183056
Cell Res. 2017 Dec;27(12):1409-1421
pubmed: 29151586
Sci China Life Sci. 2020 Jul;63(7):1079-1081
pubmed: 32170628
J Virol. 2015 Jan;89(1):2-13
pubmed: 25320305
PLoS One. 2015 Sep 25;10(9):e0138951
pubmed: 26405798
J Virol. 2015 Sep;89(17):9115-8
pubmed: 26063436
Cell Discov. 2019 Apr 16;5:21
pubmed: 30993000
J Infect Dis. 2013 Dec 15;208(12):1962-7
pubmed: 23990573
Nature. 2015 Jun 04;522(7554):102-5
pubmed: 25762140
Virology. 2019 Sep;535:232-240
pubmed: 31325838
Vaccine. 2014 Jun 12;32(28):3473-9
pubmed: 24793949
Clin Chest Med. 2017 Mar;38(1):59-70
pubmed: 28159162
BMJ Open. 2014 Jan 17;4(1):e004189
pubmed: 24441057
Nature. 2013 Jul 25;499(7459):500-3
pubmed: 23823727
Nature. 2013 Jul 25;499(7459):496-9
pubmed: 23787694
Vet Res. 2018 Oct 1;49(1):98
pubmed: 30285871
Cell Rep. 2019 Nov 19;29(8):2217-2228.e5
pubmed: 31747596
Lancet. 2013 Jun 1;381(9881):1926-32
pubmed: 23643111
Cell Host Microbe. 2010 Jun 25;7(6):440-51
pubmed: 20542248
J Virol. 2018 Jan 30;92(4):
pubmed: 29167344
PLoS One. 2013 Oct 15;8(10):e77651
pubmed: 24143251
Clin Infect Dis. 2015 May 1;60 Suppl 1:S9-10
pubmed: 25878303
N Engl J Med. 2014 Feb 6;370(6):520-32
pubmed: 23614499
Nat Commun. 2015 May 13;6:6833
pubmed: 25967273
J Virol. 2013 Nov;87(22):12471-80
pubmed: 24027321
J Immunol. 2013 Dec 1;191(11):5359-70
pubmed: 24127553
Vaccine. 2015 Apr 27;33(18):2152-8
pubmed: 25772674
J Virol. 2020 Jan 6;94(2):
pubmed: 31666373
Lancet. 2004 Feb 21;363(9409):587-93
pubmed: 14987882
Viral Immunol. 2016 May;29(4):235-43
pubmed: 26910526
Nat Commun. 2014 May 06;5:3595
pubmed: 24800963
Proc Natl Acad Sci U S A. 2015 Jan 13;112(2):548-53
pubmed: 25548189
Emerg Microbes Infect. 2012 Sep;1(9):e25
pubmed: 26038430
Annu Rev Med. 2015;66:361-71
pubmed: 25386931
Sci Rep. 2015 Jun 10;5:11233
pubmed: 26058711
Antiviral Res. 2013 Oct;100(1):207-14
pubmed: 23954322
Emerg Infect Dis. 2014 Nov;20(11):1891-4
pubmed: 25340354
Nature. 2013 Oct 10;502(7470):241-4
pubmed: 23965623
Nat Commun. 2014 Nov 20;5:5509
pubmed: 25409547
Curr Opin Virol. 2014 Apr;5:91-7
pubmed: 24705093
Vaccine. 2009 Apr 28;27(19):2580-7
pubmed: 19428864
J Virol. 2020 Jan 31;94(4):
pubmed: 31748388
Cell Host Microbe. 2016 Dec 14;20(6):810-821
pubmed: 27916476
Radiology. 2013 Sep;268(3):882-9
pubmed: 23821754
J Virol. 2015 Dec 09;90(4):2142-9
pubmed: 26656694
J Virol. 2014 Jul;88(14):8153-65
pubmed: 24807722
N Engl J Med. 2013 Jun 13;368(24):2337-9
pubmed: 23697471
Cell. 2018 Apr 5;173(2):417-429.e10
pubmed: 29625056
Viruses. 2018 Aug 28;10(9):
pubmed: 30154345
J Infect Dis. 2016 Dec 15;214(12):1937-1946
pubmed: 27738054
Curr Opin Virol. 2016 Feb;16:106-113
pubmed: 26922715
Euro Surveill. 2017 Jul 6;22(27):
pubmed: 28703705
PLoS Pathog. 2015 Feb 10;11(2):e1004642
pubmed: 25668410
Emerg Infect Dis. 2019 Oct;25(10):1988-1991
pubmed: 31310233
J Virol. 2017 Nov 14;91(23):
pubmed: 28956760
Wkly Epidemiol Rec. ;91(42):485-99
pubmed: 27766828
J Infect Dis. 2013 Jan 1;207(1):115-24
pubmed: 23087433
J Infect. 2014 Oct;69(4):358-65
pubmed: 24841136
Sci China Life Sci. 2017 Dec;60(12):1299-1306
pubmed: 29270791
Antiviral Res. 2014 Jul;107:1-5
pubmed: 24746458
Expert Rev Vaccines. 2017 Jul;16(7):1-13
pubmed: 28532182
J Virol. 1993 May;67(5):2552-8
pubmed: 7682624
PLoS One. 2015 Feb 11;10(2):e0115725
pubmed: 25671696
Emerg Infect Dis. 2017 Aug;23(8):1355-1359
pubmed: 28580900
Science. 2013 Jul 26;341(6144):410-4
pubmed: 23868922
mBio. 2020 Oct 6;11(5):
pubmed: 33024040
PLoS One. 2015 Apr 17;10(4):e0123659
pubmed: 25884801
J Virol. 2014 Feb;88(3):1684-93
pubmed: 24257602
Sci Rep. 2017 May 24;7(1):2352
pubmed: 28539661
Infect Dis Poverty. 2016 Sep 01;5(1):79
pubmed: 27580946
Eur J Immunol. 2013 Aug;43(8):2055-69
pubmed: 23681926
Nat Microbiol. 2019 Feb;4(2):306-315
pubmed: 30478290
Nat Commun. 2014 Apr 10;5:3614
pubmed: 24717798
Sci Rep. 2016 May 27;6:26624
pubmed: 27230107
Antiviral Res. 2019 Oct;170:104562
pubmed: 31323236
Curr Top Microbiol Immunol. 2014;385:63-91
pubmed: 25078920
China CDC Wkly. 2019 Nov;1(1):1-2
pubmed: 34594588
Medicine (Baltimore). 2016 Feb;95(5):e2606
pubmed: 26844470
Lancet. 2013 Jun 29;381(9885):2273-9
pubmed: 23726392
J Infect. 2017 Jul;75(1):71-75
pubmed: 28390707
Nat Commun. 2014;5:3142
pubmed: 24457975
Influenza Other Respir Viruses. 2020 Mar;14(2):162-172
pubmed: 31872547
J Virol. 2014 Jun;88(12):7016-23
pubmed: 24719414
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23807-23814
pubmed: 32873642
J Infect. 2018 Sep;77(3):205-211
pubmed: 29807090
Sci China Life Sci. 2018 Dec;61(12):1465-1473
pubmed: 30414008
Antiviral Res. 2013 Jun;98(3):476-83
pubmed: 23583287
Cell. 2019 May 16;177(5):1136-1152.e18
pubmed: 31100268
Chin Med J (Engl). 2014;127(12):2206-11
pubmed: 24931229
MMWR Morb Mortal Wkly Rep. 2017 Sep 08;66(35):928-932
pubmed: 28880856
Western Pac Surveill Response J. 2017 Jan 18;8(1):6-14
pubmed: 28409054
PLoS One. 2015 Feb 26;10(2):e0113963
pubmed: 25719901
J Infect. 2019 Oct;79(4):389-399
pubmed: 31374221
Clin Microbiol Infect. 2020 Feb;26(2):247-254
pubmed: 31229595
Sci China Life Sci. 2017 Dec;60(12):1295-1298
pubmed: 29285714
Clin Infect Dis. 2019 Mar 19;68(7):1100-1109
pubmed: 30124826
mBio. 2013 Jul 02;4(4):
pubmed: 23820393
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):769-74
pubmed: 24367104
Clin Vaccine Immunol. 2011 Oct;18(10):1710-8
pubmed: 21813657
PLoS Pathog. 2009 Mar;5(3):e1000350
pubmed: 19300497
Biosaf Health. 2019 Sep;1(2):56-58
pubmed: 32501443
Vaccine. 2015 Nov 17;33(46):6282-9
pubmed: 26432915
Trends Microbiol. 2014 Apr;22(4):183-91
pubmed: 24582528

Auteurs

William J Liu (WJ)

Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, 518114, China. liujun@ivdc.chinacdc.cn.
National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China. liujun@ivdc.chinacdc.cn.

Haixia Xiao (H)

Laboratory of Protein Engineering and Vaccines, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences (CAS), Tianjin, 300308, China.

Lianpan Dai (L)

CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.

Di Liu (D)

CAS Key Laboratory of Special Pathogens and Biosafety, Chinese Academy of Sciences, Wuhan, 430071, China.
National Virus Resource Center, Chinese Academy of Sciences, Wuhan, 430071, China.
University of Chinese Academy Sciences, Beijing, 100049, China.
Center for Influenza Research and Early Warning, Chinese Academy of Sciences, Beijing, 100101, China.

Jianjun Chen (J)

CAS Key Laboratory of Special Pathogens and Biosafety, Chinese Academy of Sciences, Wuhan, 430071, China.
National Virus Resource Center, Chinese Academy of Sciences, Wuhan, 430071, China.
University of Chinese Academy Sciences, Beijing, 100049, China.
Center for Influenza Research and Early Warning, Chinese Academy of Sciences, Beijing, 100101, China.

Xiaopeng Qi (X)

Chinese Center for Disease Control and Prevention, Beijing, 102206, China.

Yuhai Bi (Y)

Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, 518114, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
University of Chinese Academy Sciences, Beijing, 100049, China.
Center for Influenza Research and Early Warning, Chinese Academy of Sciences, Beijing, 100101, China.

Yi Shi (Y)

Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, 518114, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
University of Chinese Academy Sciences, Beijing, 100049, China.
Center for Influenza Research and Early Warning, Chinese Academy of Sciences, Beijing, 100101, China.

George F Gao (GF)

National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Chinese Center for Disease Control and Prevention, Beijing, 102206, China.

Yingxia Liu (Y)

Shenzhen Key Laboratory of Pathogen and Immunity, Shenzhen Third People's Hospital, Shenzhen, 518114, China. yingxialiu@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH